HALO logo

Halozyme Therapeutics, Inc. (HALO) P/E Ratio

PE Ratio:

15.16-0.06(-0.39%)
October 15, 2025

Summary

  • As of today, HALO price to earnings ratio is 15.16, with a fall of -0.06 (-0.39%) during the most recent trading session on October 15, 2025.
  • Over the past year, HALO PE ratio has dropped by -2.53 (-14.30%).
  • HALO PE ratio is now -94.67% below its all-time high of 284.35.

Performance

HALO PE Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherHALOvaluation metrics

PE Ratio Formula

P/E =  
Price
TTM Earnings Per Share

HALO PE Ratio Trends

PeriodPeriodPE RatioPE RatioPricePriceTTM EPSTTM EPSTTM RevenueTTM Revenue
1D1 Day-0.4%-0.4%+16.1%+8.7%
1M1 Month-12.5%-12.5%--
3M3 Months+14.4%+14.4%+16.1%+8.7%
6M6 Months-2.9%+12.8%--
YTDYTD+8.8%+38.8%--
1Y1 Year-14.3%+24.1%+69.7%+35.0%
5Y5 Years-91.9%+130.7%+2753.8%+490.6%

HALO PE Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month17.88-15.2%14.64+3.5%
3M3-Month17.88-15.2%12.77+18.7%
6M6-Month18.61-18.5%11.88+27.6%
1Y1-Year20.22-25.0%11.88+27.6%
3Y3-Year39.89-62.0%11.88+27.6%
5Y5-Year284.35-94.7%11.41+32.9%
All-TimeAll-Time284.35-94.7%11.41+32.9%

HALO PE Ratio History

DateValue
2025
15.16(+8.8%)
2024
13.93(-20.5%)
2023
17.52(-55.6%)
DateValue
2022
39.42(+169.3%)
2021
14.64(-69.1%)
2020
47.38(-11.1%)
2017
53.32

FAQ

  • What is Halozyme Therapeutics, Inc. price to earnings ratio?
  • What is the all-time high PE ratio for Halozyme Therapeutics, Inc.?
  • What is HALO price to earnings ratio year-to-date change?
  • What is Halozyme Therapeutics, Inc. PE ratio year-on-year change?

What is Halozyme Therapeutics, Inc. price to earnings ratio?

The current PE ratio of HALO is 15.16

What is the all-time high PE ratio for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high price to earnings ratio is 284.35

What is HALO price to earnings ratio year-to-date change?

Halozyme Therapeutics, Inc. price to earnings ratio has changed by +1.23 (+8.83%) since the beginning of the year

What is Halozyme Therapeutics, Inc. PE ratio year-on-year change?

Over the past year, HALO price to earnings ratio has changed by -2.53 (-14.30%)
On this page